medline.ch Gynäkologie Mammae

	Dense-MoE vs Lite-MoE: A Gating-Weight-Aware Pruning Framework for Unpaired Multimodal Breast Cancer Diagnosis. J Imaging Inform Med Cetintas D, Tuncer T, Kilicarslan G, Sevi M. PMID: 42204022 [PubMed - as supplied by publisher]
	Survival outcomes with trastuzumab deruxtecan in HER2-positive vs. HER2-low breast cancer patients with brain metastases: a real-world cohort study. Sci Rep Podder V, Sarfraz Z, Ranjan T, McCracken A, Hurmiz C, Hodgson L, Maharaj A, Mahtani R, Ahluwalia MS. PMID: 42203808 [PubMed - as supplied by publisher]
	Standard Clinical Characteristics Fail to Predict Mild Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients. Anticancer Res Rades D, Streubel MK, Staackmann C, Doehring L, Rody A, Normann Haverberg MJ, Ballegaard M. PMID: 42203308 [PubMed - indexed for MEDLINE]
	Dual drug-loaded nanofibrous scaffolds for targeting dormant breast cancer cells: design, mechanisms, and translational perspectives. Int J Pharm Malarvannan M, Yadav D, Methri SM, Natesan S, Paul D. PMID: 42203084 [PubMed - as supplied by publisher]
	UPLC-MS/MS method for quantifying non-stimulant ADHD medications in human breast milk and plasma: Application in a lactating patient receiving atomoxetine. J Pharm Biomed Anal Aoyagi R, Furugen A, Nishimura A, Umazume T, Ishikawa S, Narumi K, Okamoto K, Ueda H, Kobayashi M. PMID: 42202754 [PubMed - as supplied by publisher]
	Evaluation of breast risk at menopause: what impact on the use of menopausal hormone therapy? Maturitas Rodrigues MAH, Gompel A. PMID: 42202686 [PubMed - as supplied by publisher]
	Efficacy and safety of fat grafting in breast reconstruction: A systematic review and meta-analyses of outcomes following mastectomy. J Plast Reconstr Aesthet Surg Ahn J, Ahn J, Shiatis A, Herron J. PMID: 42202560 [PubMed - as supplied by publisher]
	Safety analyses of the INAVO120 randomised phase III trial of inavolisib or placebo with palbociclib-fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative, endocrine-resistant advanced breast cancer. ESMO Open Im SA, Kalinsky K, Jhaveri KL, Loibl S, Turner N, Saura C, Schmid P, Loi S, Hamilton E, Karadurmus N, Wang S, Awan AA, Ciruelos EM, Chung CF, Thanopoulou E, Shankar N, Lim S, Jin Y, Song C, Juric D. PMID: 42202490 [PubMed - as supplied by publisher]
	Dynamic thymidine kinase activity independently captures treatment-specific biological response and is independently associated with outcomes in endocrine-resistant HR+â€¯/HER2â€¯- metastatic breast cancer: A translational analysis of the GEICAM/2013-02 PEARL trial. Eur J Cancer Guerrero-Zotano Á, Gil-Gil M, Williams A, Ruiz-Borrego M, Ritzén H, Ciruelos EM, Muñoz M, Bermejo B, Margelí M, Antón A, Kahan Z, Csöszi T, Murillo L, Murillo SM, Lang I, Rendo CR, Alba E, Álvarez P, de la Haba-Rodriguez J, Álvarez I, García A, Herranz J, Caballero R, Fisker H, Portela M, Rojo F, Martín M. PMID: 42202479 [PubMed - as supplied by publisher]
	Whole body vibration as an alternative to conventional aerobic and resistance training for managing chemotherapy-induced peripheral neuropathy in breast cancer survivors: The sensi-ex randomized trial. Eur J Oncol Nurs Mijwel S, Backman M, Anandavadivelan P, Tofthagen C, Wengström Y. PMID: 42202439 [PubMed - as supplied by publisher]
	High-Dose Sunitinib Accelerates Triple-Negative Breast Cancer Metastasis by Modulating an Immunosuppressive Microenvironment: A Preclinical 4T1 Model Study. Pharm Res Liu C, Xue J, Wang T, Hou X, Chen D, Wang Y, Zhou T. PMID: 42204130 [PubMed - as supplied by publisher]
	Pentagamavunone-1 inhibits aggressive breast cancer cell proliferation through mitotic catastrophe and ROS-mediated activities: in vitro and in vivo studies. Saudi Pharm J Novitasari D, Nakamae I, Istighfari Jenie R, Yoneda-Kato N, Kato JY, Meiyanto E. PMID: 42204109 [PubMed]
	Optimization of Pathologists' Roles in Molecular Biomarker Testing in Metastatic Breast Cancer: A Consensus Statement. J Mol Diagn Kolhe R, Karakas C, Vail E, Deftereos G, Sidiropoulos N. PMID: 42202906 [PubMed - as supplied by publisher]
	Dynamic Evolution of HER2 Expression Following Neoadjuvant Therapy and Its Association With Treatment Response and Prognosis in Breast Cancer: A Large-Scale Retrospective Study. World J Surg Wang S, Liu T, Liu X, Liu L, Ma T, Shi Z, Liu J, Zhang J. PMID: 42202038 [PubMed - as supplied by publisher]
	ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study. Mol Oncol Stergiopoulou D, Markou A, Nicolo E, Serafini MS, Zhang Q, Zhang Y, Gerratana L, Davis AA, Liu H, Gradishar WJ, Reduzzi C, Cristofanilli M, Lianidou E. PMID: 42201922 [PubMed - as supplied by publisher]
	Early tumour size changes from neoadjuvant chemotherapy as a predictor of pathologic response in breast cancer. PLoS One Chung EZ, Alberico D, Sannachi L, Dasgupta A, Yip J, Pena MLA, Gandhi S, Curpen B, Czarnota GJ. PMID: 42201919 [PubMed - indexed for MEDLINE]
	Local genetic correlations between systemic sclerosis and common cancer types. PLoS One Patasova K, Che WI, Westerlind H, Diaz-Gallo LM, Holmqvist M. PMID: 42201917 [PubMed - indexed for MEDLINE]
	Temporal dynamics of prognostic factors in breast cancer survival. PLoS One Tvete IF, Klemp M. PMID: 42201883 [PubMed - indexed for MEDLINE]
	[Hereditary breast cancer : Syndromes, pathology, clinical aspects]. Pathologie (Heidelb) Lebeau A, Schmutzler R. PMID: 42201356 [PubMed - as supplied by publisher]
	Elucidating the molecular mechanisms linking bisphenol A to breast cancer: an integrated study of bioinformatics, machine learning, and molecular docking. Naunyn Schmiedebergs Arch Pharmacol Bu X, Ma J, Liu Q, Li T, Gao C, Li W, Luo Z. PMID: 42201343 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 218227

Seite 1 von 10912

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung